199
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

microRNA-130b-3p delivery by mesenchymal stem cells-derived exosomes confers protection on acute lung injury

, , , , , , & show all
Pages 597-607 | Received 01 Dec 2021, Accepted 18 Jun 2022, Published online: 26 Aug 2022

References

  • Parekh D, Dancer RC, Thickett DR. Acute lung injury. Clin Med (Lond). 2011;11(6):615–618.
  • Fanelli V, Ranieri VM. Mechanisms and clinical consequences of acute lung injury. Ann Am Thorac Soc. 2015;12(Suppl 1):S3–S8.
  • Mowery NT, Terzian WTH, Nelson AC. Acute lung injury. Curr Probl Surg. 2020;57(5):100777.
  • Chen H, Bai C, Wang X. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir Med. 2010;4(6):773–783.
  • D’Alessio FR. Mouse models of acute lung injury and ARDS. Methods Mol Biol. 2018;1809:341–350.
  • Xiao K, He W, Guan W, et al. Mesenchymal stem cells reverse EMT process through blocking the activation of NF-kappaB and hedgehog pathways in LPS-induced acute lung injury. Cell Death Dis. 2020;11(10):863.
  • Zhu J, Feng B, Xu Y, et al. Mesenchymal stem cells alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of Ly6C(+) CD8(+) T cells. Cell Death Dis. 2020;11(10):829.
  • Lu Z, Chang W, Meng S, et al. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury. Stem Cell Res Ther. 2019;10(1):372.
  • Yaghoubi Y, Movassaghpour A, Zamani M, et al. Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment. Life Sci. 2019;233:116733.
  • Yi X, Wei X, Lv H, et al. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3. Exp Cell Res. 2019;383(2):111454.
  • Wei X, Yi X, Lv H, et al. MicroRNA-377-3p released by mesenchymal stem cell exosomes ameliorates lipopolysaccharide-induced acute lung injury by targeting RPTOR to induce autophagy. Cell Death Dis. 2020;11(8):657.
  • Rajasekaran S, Pattarayan D, Rajaguru P, et al. MicroRNA regulation of acute lung injury and acute respiratory distress syndrome. J Cell Physiol. 2016;231(10):2097–2106.
  • Wang P, Zhang X, Li F, et al. MiR-130b attenuates vascular inflammation via negatively regulating tumor progression locus 2 (Tpl2) expression. Int Immunopharmacol. 2017;51:9–16.
  • Zhang H, Ding Y, Hou Y, et al. Bone marrow mesenchymal stem cells derived miRNA-130b enhances epithelial sodium channel by targeting PTEN. Respir Res. 2020;21(1):329.
  • Li S, Geng J, Xu X, et al. miR-130b-3p modulates Epithelial-Mesenchymal crosstalk in lung fibrosis by targeting IGF-1. PLoS One. 2016;11(3):e0150418.
  • Guo Q, Zhu X, Wei R, et al. miR-130b-3p regulates M1 macrophage polarization via targeting IRF1. J Cell Physiol. 2021;236(3):2008–2022.
  • Lee TH, Yeh CF, Lee YT, et al. Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGFbeta signaling through TGFBR1 stabilization. Nat Commun. 2020;11(1):4254.
  • Cheng D, Xu Q, Liu Y, et al. Long noncoding RNA-SNHG20 promotes silica-induced pulmonary fibrosis by miR-490-3p/TGFBR1 axis. Toxicology. 2021;451:152683.
  • Zhou LL, He XY, Xu FY, et al. Chitosan aerosol inhalation alleviates lipopolysaccharide- induced pulmonary fibrosis in rats. Exp Lung Res. 2014;40(9):467–473.
  • Zhang YQ, Liu YJ, Mao YF, et al. Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of oxidative stress and transforming growth factor-beta1 signaling. Clin Nutr. 2015;34(4):752–760.
  • Seok J, Park H, Choi JH, et al. Placenta-derived mesenchymal stem cells restore the ovary function in an ovariectomized rat model via an antioxidant effect. Antioxidants (Basel). 2020;9(7):591.
  • Liu J, Chen T, Lei P, et al. Exosomes released by bone marrow mesenchymal stem cells attenuate lung injury induced by intestinal ischemia reperfusion via the TLR4/NF-kappaB pathway. Int J Med Sci. 2019;16(9):1238–1244.
  • Yu L, Gui S, Liu Y, et al. Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2. Aging (Albany NY). 2019;11(15):5300–5318.
  • Zhang C, Guo F, Chang M, et al. Exosome-delivered syndecan-1 rescues acute lung injury via a FAK/p190RhoGAP/RhoA/ROCK/NF-kappaB signaling axis and glycocalyx enhancement. Exp Cell Res. 2019;384(1):111596.
  • Li H, Shi H, Gao M, et al. Long non-coding RNA CASC2 improved acute lung injury by regulating miR-144-3p/AQP1 axis to reduce lung epithelial cell apoptosis. Cell Biosci. 2018;8:15.
  • Wang C, Lv D, Zhang X, et al. Interleukin-10-Overexpressing mesenchymal stromal cells induce a series of regulatory effects in the inflammatory system and promote the survival of Endotoxin-Induced acute lung injury in mice model. DNA Cell Biol. 2018;37(1):53–61.
  • Gong J, Wu ZY, Qi H, et al. Maresin 1 mitigates LPS-induced acute lung injury in mice. Br J Pharmacol. 2014;171(14):3539–3550.
  • Wang T, Jiang L, Wei X, et al. Inhibition of miR-221 alleviates LPS-induced acute lung injury via inactivation of SOCS1/NF-kappaB signaling pathway. Cell Cycle. 2019;18(16):1893–1907.
  • Xie W, Lu Q, Wang K, et al. miR-34b-5p inhibition attenuates lung inflammation and apoptosis in an LPS-induced acute lung injury mouse model by targeting progranulin. J Cell Physiol. 2018;233(9):6615–6631.
  • Alghetaa H, Mohammed A, Sultan M, et al. Resveratrol protects mice against SEB-induced acute lung injury and mortality by miR-193a modulation that targets TGF-beta signalling. J Cell Mol Med. 2018;22(5):2644–2655.
  • Kaspi H, Semo J, Abramov N, et al. MSC-NTF (NurOwn(R)) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model. Stem Cell Res Ther. 2021;12(1):72.
  • Zhang C, Guo Z, Liu H, et al. Influence of levosimendan postconditioning on apoptosis of rat lung cells in a model of ischemia-reperfusion injury. PLoS One. 2015;10(1):e0114963.
  • Xie H, Gao YM, Zhang YC, et al. Low let-7d exosomes from pulmonary vascular endothelial cells drive lung pericyte fibrosis through the TGFbetaRI/FoxM1/smad/beta-catenin pathway. J Cell Mol Med. 2020;24(23):13913–13926.
  • Liu S, Yang Y, Jiang S, et al. MiR-378a-5p regulates proliferation and migration in vascular smooth muscle cell by targeting CDK1. Front Genet. 2019;10:22.
  • Song Y, Li Z, He T, et al. M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124. Theranostics. 2019;9(10):2910–2923.
  • Ma C, Liu Y, Ma Y, et al. Identification and characterization of pulmonary mesenchymal stem cells derived from rat fetal lung tissue. Tissue Cell. 2021;73:101628.
  • Schmelzer E, McKeel DT, Gerlach JC. Characterization of human mesenchymal stem cells from different tissues and their membrane encasement for prospective transplantation therapies. Biomed Res Int. 2019;2019:6376271.
  • Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006;91(8):1017–1026.
  • Yuan J, Li P, Pan H, et al. miR-770-5p inhibits the activation of pulmonary fibroblasts and silica-induced pulmonary fibrosis through targeting TGFBR1. Ecotoxicol Environ Saf. 2021;220:112372.
  • Bhargava M, Wendt CH. Biomarkers in acute lung injury. Transl Res. 2012;159(4):205–217.
  • Monsel A, Zhu YG, Gudapati V, et al. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases. Expert Opin Biol Ther. 2016;16(7):859–871.
  • Zhu YG, Feng XM, Abbott J, et al. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells. 2014;32(1):116–125.
  • Li J, Deng X, Ji X, et al. Mesenchymal stem cell exosomes reverse acute lung injury through nrf-2/ARE and NF-kappaB signaling pathways. PeerJ. 2020;8:e9928.
  • Xu N, Shao Y, Ye K, et al. Mesenchymal stem cell-derived exosomes attenuate phosgene-induced acute lung injury in rats. Inhal Toxicol. 2019;31(2):52–60.
  • Li QC, Liang Y, Su ZB. Prophylactic treatment with MSC-derived exosomes attenuates traumatic acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol. 2019;316(6):L1107–L1117.
  • Liu JS, Du J, Cheng X, et al. Exosomal miR-451 from human umbilical cord mesenchymal stem cells attenuates burn-induced acute lung injury. J Chin Med Assoc. 2019;82(12):895–901.
  • Gurien SD, Aziz M, Jin H, et al. Extracellular microRNA 130b-3p inhibits eCIRP-induced inflammation. EMBO Rep. 2020;21(1):e48075.
  • Jin M, Lee J, Lee KY, et al. Alteration of TGF-beta-ALK-Smad signaling in hyperoxia-induced bronchopulmonary dysplasia model of newborn rats. Exp Lung Res. 2016;42(7):354–364.
  • Lee Y, Lee J, Nam SK, et al. S-endoglin expression is induced in hyperoxia and contributes to altered pulmonary angiogenesis in bronchopulmonary dysplasia development. Sci Rep. 2020;10(1):3043.
  • Park SA, Kim MJ, Park SY, et al. EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-beta/smad and ROS signaling. Cell Mol Life Sci. 2015;72(10):2023–2039.
  • Li J, Liu J, Yue W, et al. Andrographolide attenuates epithelial-mesenchymal transition induced by TGF-beta1 in alveolar epithelial cells. J Cell Mol Med. 2020;24(18):10501–10511.
  • Cedilak M, Banjanac M, Belamaric D, et al. Precision-cut lung slices from bleomycin treated animals as a model for testing potential therapies for idiopathic pulmonary fibrosis. Pulm Pharmacol Ther. 2019;55:75–83.
  • Liu JH, Li C, Cao L, et al. Exosomal miR-132-3p from mesenchymal stem cells alleviated LPS-induced acute lung injury by repressing TRAF6. Autoimmunity. 2021;54(8):493–503.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.